Coca-Cola HBC AG (LON:CCH – Get Rating) passed below its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of GBX 1,952.04 ($23.78) and traded as low as GBX 1,920.50 ($23.40). Coca-Cola HBC shares last traded at GBX 1,926.50 ($23.47), with a volume of 759,508 shares.
Analysts Set New Price Targets
CCH has been the topic of several analyst reports. Citigroup restated a “neutral” rating on shares of Coca-Cola HBC in a research report on Wednesday, November 9th. Barclays lowered their target price on Coca-Cola HBC from GBX 2,600 ($31.68) to GBX 2,500 ($30.46) and set an “overweight” rating on the stock in a research report on Wednesday, November 9th. JPMorgan Chase & Co. restated a “neutral” rating and issued a GBX 1,900 ($23.15) target price on shares of Coca-Cola HBC in a research report on Wednesday, November 9th. Finally, Deutsche Bank Aktiengesellschaft raised their target price on Coca-Cola HBC from GBX 2,750 ($33.50) to GBX 2,950 ($35.94) and gave the company a “buy” rating in a research report on Wednesday, November 9th. Three research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of GBX 2,210 ($26.92).
Coca-Cola HBC Trading Down 0.5 %
The company has a market capitalization of £7.06 billion and a price-to-earnings ratio of 1,505.08. The firm has a 50-day moving average price of GBX 1,980.51 and a 200-day moving average price of GBX 1,952.04. The company has a current ratio of 1.02, a quick ratio of 0.80 and a debt-to-equity ratio of 101.90.
Coca-Cola HBC Company Profile
Coca-Cola HBC AG engages in the production, distribution, and sale of non-alcoholic ready-to-drink beverages worldwide. The company offers sparkling soft drinks, hydration drinks, juices, ready-to-drink tea, energy drinks, coffee, water, plant-based drinks, premium spirits and flavored alcoholic beverages, and snacks.
- 3 Small-Cap Biopharma Stocks that Could See Big Growth in 2023
- Optimism About Global Demand For Metals Boosts BHP, Other Miners
- Exxon Mobil Expects Earnings and Cash Flow to Grow
- Sorrento Therapeutics, Scilex: 2 Hot Pharma Stocks On the Move
- Is The Great Alibaba Recovery About To Begin?
Receive News & Ratings for Coca-Cola HBC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Coca-Cola HBC and related companies with MarketBeat.com's FREE daily email newsletter.